Arrhythmias & electrophysiology

Epinephrine Challenge: Long-Term Evaluation of Test Performance for the Evaluation of Unexplained Cardiac Arrest and Familial Sudden Death

JACC Clin ElectrophysiolPublished Diagnostic test performance study in a registry

Authors' conclusion

A positive epinephrine challenge demonstrated mild-moderate agreement with a final diagnosis of LQTS and CPVT. Most patients with an initial positive test result had their diagnosis revised to UCA, unaffected, or an alternative diagnosis over long-term follow-up. This study suggests that epinephrine challenge has limited utility as a "rule-in" test but may retain value in its negative predictive value for the UCA population.

Study context

Population
Consecutive patients undergoing epinephrine challenge in the Hearts in Rhythm Organization registry: patients with unexplained cardiac arrest (UCA) and first-degree relativesconsecutive patients undergoing epinephrine challenge · patients with unexplained cardiac arrest [UCA] 250 · first-degree relatives 176
Participants
376 patients
Comparison
Epinephrine challenge for the diagnosis of long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT), comparing to final working diagnosis according to guideline-derived diagnostic criteria
Outcome
Test performance of epinephrine for the diagnosis of LQTS
Follow-up
Mean 8.6 ± 5.3 years
Methodological detailsconsecutive patients, long-term follow-up
  • Consecutive patients
  • Long-term follow-up

Performance

As reported in the abstract

Test or modelSensitivitySpecificityLR+Likelihood ratio (LR-)
Epinephrine challenge90%79%4.4 (95% CI: 3.4-5.6)0.1 (95% CI: 0.0-0.4)

Epinephrine challenge

Sensitivity90%
Specificity79%
LR+4.4 (95% CI: 3.4-5.6)
Likelihood ratio (LR-)0.1 (95% CI: 0.0-0.4)

Further findings

OutcomeEpinephrine challenge
Test performance of epinephrine for the diagnosis of CPVTCompared with final working diagnosis
Sensitivity62%
Specificity93%
LR+8.9 (95% CI: 5.2-16.6)
LR-0.4 (95% CI: 0.2-0.8)

QT prolongation with epinephrine vs end-recovery QTc on exercise stress testing

No significant correlation

Pathogenic variant yield among patients with a positive epinephrine challenge

Pathogenic LQTS variant, of genotyped patients with a positive epinephrine challenge for LQTS
15%
Pathogenic CPVT variant, of patients with a positive epinephrine challenge for CPVT
13%

Final working diagnosis of patients with a positive epinephrine challenge

Most had a "non-LQTS/CPVT" final working diagnosis (either UCA, unaffected, or an alternative Inherited arrhythmia syndrome)

Original publication

Epinephrine Challenge: Long-Term Evaluation of Test Performance for the Evaluation of Unexplained Cardiac Arrest and Familial Sudden Death. JACC Clin Electrophysiol. Published 14 May 2026. doi:10.1016/j.jacep.2026.03.033

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.